{"created":"2023-06-19T11:39:52.329212+00:00","id":8083,"links":{},"metadata":{"_buckets":{"deposit":"eb32aadd-4d18-40e1-89e2-11c2ec5b20bc"},"_deposit":{"created_by":15,"id":"8083","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"8083"},"status":"published"},"_oai":{"id":"oai:mie-u.repo.nii.ac.jp:00008083","sets":["334:627:1692670376097"]},"author_link":["19873"],"item_8_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2015-05-20","bibliographicIssueDateType":"Issued"}}]},"item_8_description_14":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_8_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"英国の非営利団体であるCancer Research UK（CRUK）は、数百億円の寄付金で開発を実施し、本格的な新薬候補を製薬企業に提供していた。CRUKの事例はＮＰＯ創薬の成功モデルである。台湾では慈済基金会が寄付を基に台湾第2位の医療組織を形成し、患者に最適な医療を実現していた。慈済基金会の取組は、病院経営に「非営利（＝寄付収入）」と「営利（＝医療収入）」の異なる手法を融合することが、「医療の質向上」につながることを示唆した。","subitem_description_type":"Abstract"},{"subitem_description":"The Cancer Research UK (CRUK) which is a British non-profit organization carried out development by donation of tens of billion yen and provides a new drug candidate to the drug industry. An example of CRUK is a success model of the NPO innovative drug development. In Taiwan, Buddhist Compassion Relief Tzu Chi Foundation forms the Taiwanese second largest medical organization based on donation and realizes the medical care that is most suitable for a patient. The action of Tzu Chi Foundation suggested that the introduction of a fusion of \"\"nonprofit way (donation income) and the profit way (medical care income)\"\" to the hospital management could realize the medical quality improvement.","subitem_description_type":"Abstract"}]},"item_8_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"2013年度～2014年度科学研究費補助金(挑戦的萌芽研究)研究成果報告書","subitem_description_type":"Other"}]},"item_8_description_64":{"attribute_name":"科研費番号","attribute_value_mlt":[{"subitem_description":"25590073","subitem_description_type":"Other"}]},"item_8_publisher_30":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"三重大学"}]},"item_8_text_18":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_text_value":"Study of new innovative drug development venture business model which appeared in the times of the personalized medicine"}]},"item_8_text_65":{"attribute_name":"資源タイプ（三重大）","attribute_value_mlt":[{"subitem_text_value":"Kaken / 科研費報告書"}]},"item_8_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"西村, 訓弘","creatorNameLang":"ja"},{"creatorName":"NISHIMURA, Norihiro","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-02-18"}],"displaytype":"detail","filename":"30K17898.pdf","filesize":[{"value":"354.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"30K17898.pdf","url":"https://mie-u.repo.nii.ac.jp/record/8083/files/30K17898.pdf"},"version_id":"ef301afa-f646-499f-a233-85197e949b22"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"創薬","subitem_subject_scheme":"Other"},{"subitem_subject":"ビジネスモデル","subitem_subject_scheme":"Other"},{"subitem_subject":"台湾","subitem_subject_scheme":"Other"},{"subitem_subject":"英国","subitem_subject_scheme":"Other"},{"subitem_subject":"個別化医療","subitem_subject_scheme":"Other"},{"subitem_subject":"非営利団体","subitem_subject_scheme":"Other"},{"subitem_subject":"技術移転","subitem_subject_scheme":"Other"},{"subitem_subject":"ベンチャー","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"research report","resourceuri":"http://purl.org/coar/resource_type/c_18ws"}]},"item_title":"個別化医療の時代に出現した新たな創薬ベンチャー・モデルに関する研究","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"個別化医療の時代に出現した新たな創薬ベンチャー・モデルに関する研究","subitem_title_language":"ja"}]},"item_type_id":"8","owner":"15","path":["1692670376097"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2017-01-13"},"publish_date":"2017-01-13","publish_status":"0","recid":"8083","relation_version_is_last":true,"title":["個別化医療の時代に出現した新たな創薬ベンチャー・モデルに関する研究"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2023-11-07T04:40:33.583699+00:00"}